Analysis of drug abuse data reported by medical institutions in Taiwan from 2002 to 2011

Journal of Food and Drug Analysis

Volumn 22, Issue 2, 2014, Pages 169-177

  Hsu, Jui ^a   Lin, Jii Jun ^a   Tsay, Wen Ing ^a  

^a Executive Yuan   (Taiwan)

Author keywords

Drug abuse; Heroin; Ketamine; Methamphetamine; Zolpidem

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DIAMORPHINE; ILLICIT DRUG; KETAMINE; METHAMPHETAMINE; ZOLPIDEM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; DEMOGRAPHY; DRUG ABUSE; DRUG DEPENDENCE; DRUG MONITORING; DRUG OVERDOSE; FEMALE; HARM REDUCTION; HEALTH CARE ACCESS; HEPATITIS B; HUMAN; INHALATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METHADONE TREATMENT; PUBLIC HEALTH PROBLEM; REVIEW; SMOKING; SNIFFING; TAIWAN; TELEVISION;

EID: 84914700720     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2014.01.019     Document Type: Article

References (40)

1. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality. The DAWN report: highlights of the 2011 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. Rockville: Center for Behavioral Health Statistics and Quality; 2013.
2. United Nations Office on Drugs and Crime (UNODC).World Drug Report 2012. Publication No. E.12.XI.1. Vienna: UNODC; 2012.
3. World Health Organization (WHO). Atlas on substance use (2010): resources for the prevention and treatment of substance use disorders. Geneva: WHO; 2010.
4. United Nations (UN), Department of Economic and Social Affairs, Population Division. World population prospects: The 2010 revision. http://esa.unorg/unpd/wpp.
5. United Nations Office on Drugs and Crime(UNODC).World Drug Report 2011. Publication No. E.11.XI.10. Vienna: UNODC; 2011.
6. United Nations Officeon Drugs and Crime(UNODC).World Drug Report 2010. Publication No. E.10.XI.13. Vienna: UNODC; 2010.
7. United Nations Officeon Drugsand Crime(UNODC).World Drug Report 2009. Publication No. E.09.XI.12. Vienna: UNODC; 2009.
8. United Nations Officeon Drugsand Crime(UNODC).World Drug Report 2008. Publication No. E.08.XI.1. Vienna: UNODC; 2008.
9. National Bureau of Controlled Drugs. Bureau of Health Promotion and National Health Research Institutes. Report no. 2:drugabusesurveyon2009NationalHealthInterviewandDrug Abuse Survey in Taiwan. Taiwan: Department of Health; 2009.
10. Li JH. Evolution of the legislative and administrative system of controlled drugs in Taiwan. J Food Drug Analysis 2012;20:778-85.
11. Li JH, Liu SF, Yu WJ. Patterns and trends of drug abuse in Taiwan: A brief history and report from 2000 through 2004. In: Epidemiologic trends in drug abuse, Volume II, Proceedings of the Community Epidemiology Work Group, 2005 June, Denver, CO. Bethesda: MasiMax Resources, Inc., National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services; 2006. [N01-DA-1-5514 from NIDA].
12. Li JH, Lu MI. Patternsand trends of drug abuse in Taiwan, R.O.C.: report of 1998 and 1999. International Monograph Series No. 16. In: NavaratnamV, Wong P-L, editors. Report of the Asian Multicity Epidemiology Work Group 2002. Penang: Centre for Drug Research, Universiti Sains Malaysia; 2003. p. 8-16.
13. National Bureau of Controlled Drugs. Bureau of Health Promotion and National Health Research Institutes. Report no. 2: drug abuse survey on 2005 National Health Interview and Drug Abuse Survey in Taiwan. Taiwan: Department of Health; 2005.
14. Erowid. Heroin legal status. The Vaults of Erowid. Available at: http://www.erowid.org/chemicals/heroin/heroin-law.shtml (accessed 28.02.13).
15. Wikipedia. Legal status of methamphetamine. Wikipedia, the free encyclopedia. Available at: http://en.wikipedia.org/wiki/Legal-status-of-methamphetamine (accessed 28.02.13).
16. United Nations Office on Drugs and Crime (UNODC). Patterns and trends of amphetamine-type stimulants and other drugs: Asia and the Pacific, 2011da report from the Global SMART Program. Vienna: UNODC; 2011.
17. Taiwan Department of Health. Statistics of drug abuse cases and laboratory testing, November 2012. Taipei: Department of Health; 2012.
18. Jansen KL, Darracot-Cankovic R. The nonmedical use of ketamine, part two: A review of problem use and dependence. J Psychoactive Drugs 2001;33:151-8.
19. Srirangam S, Mercer J. Ketamine bladder syndrome: An important differential diagnosis when assessing a patient with persistent lower urinary tract symptoms. BMJ Case Rep; 2012. http://dx.doi.org/10.1136/bcr-2012-006447.
20. Dalgarno PJ, Shewan D. Illicit use of ketamine in Scotland. J Psychoactive Drugs 1996;283:191-9.
21. Kalsi SS, Wood DM, Dargan PI. The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J 2011;4. http://dx.doi.org/10.3402/ehtj.v4i0.7107.
22. Olkkola KT, Ahonen J. Midazolam and other benzodiazepines. Handb Exp Pharmacol 2008;182:335-60.
23. Dikeos DG, Theleritis CG, Soldatos CR. Benzodiazepines: effects on sleep. In: Pandi-Perumal SR, editor. Sleep disorders: diagnosis and therapeutics. New York: Informa Healthcare; 2008. p. 220-2.
24. Siriwardena AN, Qureshi MZ, Dyas JV, et al. Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. Br J Gen Pract 2008;58:417-22.
25. International Narcotics Control Board. List of psychotropic substances under international control. Available at: http://www.incb.org/incb/en/narcotic-drugs/Yellowlist-Forms/yellow-list.html (accessed 01.03.13).
26. International Narcotics Control Board. Report of the International Narcotics Control Board for 2006. Vienna: United Nations (UN); 2007.
27. Substance Abuse and Mental Health Services Administration. 2010 National survey on drug use and health: Summary of national findings. Rockville, MD: NSDUH Series H-41, HHS Publication No. SMA 11e4658.
28. Australian Institute of Health and Welfare. 2010 National Drug Strategy Household Survey Report, Drug Statistics Series, No. 25. Canberra: Australian Institute of Health and Welfare; 2011.
29. National Institute on Drug Abuse. Prescription drugs: Abuse and addiction. Research Report Series. NIH Publication Number 11-4881, printed July 2001, revised October 2011. Bethesda, MD: National Institute on Drug Abuse; 2011.
30. European Monitoring Centre for Drugs and Drug Addiction. Annual report 2012: The state of the drugs problemin Europe. Luxembourg: Publications Office of the European Union; 2012.
31. European Monitoring Centre for Drugs and Drug Addiction. Annual report 2011: The state of the drugs problem in Europe. Luxembourg: Publications Office of the European Union; 2011.
32. United Nations (UN). Amphetamines and ecstasy: 2011 global ATS assessment. Publication No. E.11.XI.13. Vienna: UN; 2011.
33. National Drug and Alcohol Research Centre (NDARC). synthetic drugs tighten their grip; users risking "no name" capsules. 2012. Available at. Increase in ecstasy among Australia's recreational drug users. University of New South Wales; March 3, 2013. Accessed, http://ndarc.med.unsw.edu.au/news/increase-ecstasy-among-australia%E2%80%99s-recreational-drug-users-synthetic-drugs-tighten-theirgrip.
34. Lee SF, Hsu J, Tsay WI. The trend of drug abuse in Taiwan during year 1999 to 2011. J Food Drug Anal 2013;21:390-6.
35. NationalDrug andAlcoholResearchCentre (NDARC), University of New SouthWales. Drug experts warn of rapid changes in Internetmarketplace for illicit drugs and "legal" highs.Available at: http://ndarc.med.unsw.edu.au/news/drug-experts-warnrapid-changes-internet-marketplace-illicit-drugs-and-%E2%80%9Clegal%E2%80%9D-highs; 2012 (accessed 03.03.13).
36. Degenhardt L, Dierker L, Chiu WT, et al. Evaluating the drug use "gateway" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend 2010;108:84-97.
37. Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet 2008;372:1733-45.
38. Daniel C, Maxim G, Shabtai L, et al. Epidemiology of hepatitis B, hepatitis C and HIV infections among intravenous drug users in Jersusalem, Israel. International Public Health Journal 2010;2:345-50.
39. Hang H, Des Jarlaris DC. HIV and HCV infection among injecting drug users. Mt Sinai J Med 2000;67:423-8.
40. Roy K, Hay G, Andregetti R, et al. Monitoring hepatitis C virus infection among injecting drug users in the European Union: A review of the literature. Epidemiol Infect 2002;129:577-85.